Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
6
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
N/ANon-phased studies
6(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Terminated(3)

Detailed Status

Recruiting2
Withdrawn2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A6 (100.0%)

Trials by Status

completed117%
recruiting233%
terminated117%
withdrawn233%

Recent Activity

2 active trials
Showing 5 of 6
recruitingnot_applicable

MMA Embolization for Refractory Chronic Migraine

NCT06735833
withdrawnnot_applicable

Middle Meningeal Artery Embolization for Chronic Migraine

NCT07044648
terminatednot_applicable

The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma

NCT04742920
recruitingnot_applicable

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

NCT06772740
completednot_applicable

Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine

NCT06029153
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06735833Not Applicable

MMA Embolization for Refractory Chronic Migraine

Recruiting
NCT07044648Not Applicable

Middle Meningeal Artery Embolization for Chronic Migraine

Withdrawn
NCT04742920Not Applicable

The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma

Terminated
NCT06772740Not Applicable

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

Recruiting
NCT06029153Not Applicable

Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine

Completed
NCT04500795Not Applicable

Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6